SKI Market

Indian Indices

Sensex

82,566.37 221.69
( 0.27%)

Global Indices

Nasdaq

49,020.90 -412.51
(-0.83%)

Dow Jones

6,999.25 28.02
(0.40%)

Hang Seng

53,521.14 162.43
(0.30%)

Nikkei 225

10,178.80 -29.00
(-0.28%)

Forex

USD-INR

91.63 -0.01
(-0.02%)

EUR-INR

109.29 0.55
(0.50%)

GBP-INR

125.84 0.55
(0.44%)

JPY-INR

0.60 0.00
(0.30%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Ajanta Pharma Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

532331

INE031B01049

330.3875196

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

AJANTPHARM

35.72

33946.88

EPS(TTM)

Face Value()

Div & Yield %

76.07

1.03

Back

GOCL Corporation consolidated net profit rises 157.90% in the September 2025 quarter

Nov 14,2025

Net profit of GOCL Corporation rose 157.90% to Rs 14.03 crore in the quarter ended September 2025 as against Rs 5.44 crore during the previous quarter ended September 2024. Sales declined 35.28% to Rs 2.22 crore in the quarter ended September 2025 as against Rs 3.43 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	2.22	3.43	-35
OPM %	-327.03	-116.33	-
PBDT	34.07	27.18	25
PBT	33.49	26.59	26
NP	14.03	5.44	158

82,566.37 221.69 ( 0.27%)

49,020.90 -412.51 (-0.83%)

6,999.25 28.02 (0.40%)

53,521.14 162.43 (0.30%)

10,178.80 -29.00 (-0.28%)

91.63 -0.01 (-0.02%)

109.29 0.55 (0.50%)

125.84 0.55 (0.44%)

0.60 0.00 (0.30%)